Under steady-state conditions, the CNS hosts a heterogeneous population of myeloid cells, including parenchymal microglia and nonparenchymal perivascular, subdural meningeal and choroid plexus macrophages [1] [2] [3] . The latter myeloid cells are critical effectors and regulators of immune responses at CNS borders during virtually all neuroinflammatory, neurodegenerative and neuro-oncological diseases.
A r t i c l e s localized in close vicinity to ER-TR7 + fibroblast-like cells that line the meninges and meningeal vasculature 17 . Finally, cpMΦ are found exclusively in the stroma and epithelial layer of the choroid plexus. Using confocal microscopy and subsequent three-dimensional reconstruction of brain tissue from mice in which one allele of the gene encoding the cytokine receptor CX 3 CR1 contains the gene encoding GFP (Cx3cr1 GFP/WT ), we were able to accordingly identify Iba-1 + CX 3 CR1 + pvMΦ on the basis of their close proximity to the abluminal side of endothelial cells (CD31 + ) between the endothelial and the parenchymal basement membrane (laminin + ), the perivascular space (Fig. 1b) . In the subdural meninges, we localized Iba-1 + CX 3 CR1 + mMΦ by their close proximity to fibroblasts expressing ER-TR7 (Fig. 1c) .
We then used an unbiased, surface marker-free approach to thoroughly molecularly characterize cortical microglia and cortical pvMΦ. For that purpose, we prepared a whole-cortex cell suspension devoid of meninges and choroid plexus. We then performed unbiased quantitative single-cell RNA sequencing of microglia, pvMΦ, their proposed precursors, the monocytes and peritoneal macrophages (ptMΦ) (Fig. 1d and Supplementary Figs. 1 and 2) . Individual RNA molecules were counted using unique molecular identifiers (UMIs) as described previously 18 , which greatly reduces PCR amplification bias. Dimensionality reduction using t-distributed stochastic network embedding (t-SNE) 19 revealed that pvMΦ and microglia were transcriptionally closely related, whereas monocytes and ptMΦ had a distinct RNA profile. All myeloid populations expressed the genes encoding the markers CX 3 CR1, CSF-1R and Iba-1 (Fig. 1e) , but pvMΦ were distinguishable from microglia on the basis of their expression of Mrc1 (encoding CD206) and Cd36 (Fig. 1f) . Microglia expressed higher levels of P2ry12 and Hexb than pvMΦ (Fig. 1g) , whereas monocytes exclusively expressed Cdc20 (Supplementary Fig. 1 ). Notably, Ptprc (encoding CD45) mRNA transcript expression was higher in pvMΦ than in microglia (Fig. 1e) , which could be confirmed at the protein level for all nonparenchymal macrophages in situ, but not for microglia (Fig. 1h) . Furthermore, the detection of CD206 protein on Cx3cr1 GFP/WT pvMΦ located in the perivascular space (laminin + ), but not on parenchymal microglia, is consistent with our findings on RNA level (Fig. 1i) . Flow cytometry-based separation of CD45 hi CD11b + CD206 + pvMΦ and CD45 lo CD11b + CD206 − microglia from mouse cortex that was free of meninges and choroid plexus enabled us to confirm the results obtained from the single-cell RNA sequencing on the protein level in a quantitative manner (Fig. 1j,k and Supplementary Fig. 2 ).
Taken together, these data show a close transcriptional relationship between non-parenchymal macrophages such as pvMΦ and microglia, albeit with some cell type-specific differences. 
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Prenatal origin of CNS macrophages
The current concept that macrophages at CNS borders are derived from blood-borne myeloid cells during adulthood largely depends on previous work on BM chimeras using irradiation of the recipient 20, 21 , a finding that we were able to confirm by transplanting BM from Acta1-GFP mice, which ubiquitously express GFP in all cells of the body, into irradiated hosts, which led to a vigorous engraftment of donor-derived GFP + Iba-1 + macrophages in the subdural meninges, perivascular spaces and choroid plexus, whereas microglial exchange was limited (Supplementary Fig. 3 ). However, in several organs, resident macrophages arise from embryonic precursors in the yolk sac or fetal liver that seed the tissue before birth [5] [6] [7] [22] [23] [24] . Consistent with these findings, we observed Cx3cr1 GFP/WT macrophages in the subdural meninges at embryonic day 9.5 (E9.5) and shortly thereafter in the choroid plexus and the perivascular spaces (Fig. 2) , suggesting prenatal seeding of tissue macrophages in these compartments. To test whether embryonic progenitors indeed contribute to the pool of CNS macrophages, we adapted a Cx3cr1 CreER mouse system that allows fate-mapping studies by tamoxifen-induced recombination in Cx3cr1-expressing cells at defined time points 25, 26 . Timed pregnancies were set up to generate Cx3cr1 CreER Rosa26-YFP embryos that undergo recombination and subsequently express YFP under the control of the Rosa26 promoter after a single intraperitoneal injection of tamoxifen in pregnant wild-type mice at E9.0 to pulse Cx3cr1-expressing progenitor cells in the embryo (Supplementary Fig. 3a) . This approach induced irreversible expression of YFP in Cx3cr1-expressing cells and their progeny. At E16.0, 55.4 ± 3.3% Iba-1 + mMΦ, 51.3 ± 11.5% Iba-1 + cpMΦ and 36.2 ± 7.5% Iba-1 + microglia expressed YFP, indicating robust labeling efficiency of the CX 3 CR1 + progenitors (Fig. 3a,b) . Although YFP + pvMΦ could be recognized at this embryonic stage, they were too sparse to allow a reliable quantification in Cx3cr1 CreER Rosa26-YFP embryos. Considering that microglia are entirely of prenatal origin (for example, from the yolk sac 3,5 ), we could also assume that pvMΦ, mMΦ and cpMΦ have their major source in embryonic hematopoietic sources such as the yolk sac. However, Cx3cr1-expressing myeloid progenitor cells are also found in the fetal liver 22 , which was why CNS macrophages could be derived from this prenatal source as well.
Not only microglia, but also pvMΦ and mMΦ, retained the YFP label in 6-week-old mice, demonstrating that embryonic labeling persisted into adulthood (Fig. 3c,d ). In contrast, cpMΦ lost their YFP label over time, indicating that embryo-derived cells were replaced in the choroid plexus. Expression of YFP in pvMΦ in the perivascular space was confirmed by immunoelectron microscopy (Fig. 3e) . Several transcription factors have been shown to be important for lineage commitment in myeloid cells 27, 28 . To determine which transcription factors are required for non-parenchymal CNS MΦ development, we investigated the presence of CNS macrophages in mutants lacking Sfpi1 (encoding PU.1), Irf8, Myb and Batf3 (Fig. 3f-h and Supplementary Fig. 4a ). Mice lacking PU.1 were devoid of any pvMΦ, mMΦ and cpMΦ. Notably, we found a reduction in the numbers of mMΦ, but not cpMΦ, in Irf8 −/− mice, whereas the absence of the master transcription factor for stem cell development in the BM, MYB, did not impair mMΦ and cpMΦ development, similar to its redundant role for yolk sac-derived macrophages such as microglia 6 . Batf3 deficiency did not impair the development of any of the investigated macrophage populations. In summary, our data suggest mMΦ, pvMΦ, cpMΦ and microglia are all of prenatal origin, either from the yolk sac and/or the fetal liver, and largely depend on similar transcription factors for proper development.
Maintenance of pvM, mM and cpM in adulthood
Once established in the CNS, microglia persist throughout the entire life of the organism without any substantial input from circulating blood cells as a result of their longevity and their capacity for 
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A r t i c l e s self-renewal 13, 29 . Thus, we sought to use this unique feature of microglia to compare their exchange kinetics with mMΦ, pvMΦ, cpMΦ and blood cells, such as monocytes. We treated adult Cx3cr1 CreER Rosa26-YFP mice 25, 26 with tamoxifen and determined mMΦ, pvMΦ and cpMΦ labeling at several time points after application ( Supplementary Fig. 3b ). Flow cytometry revealed long-term labeling of YFP + CD45 hi CD11b + non-parenchymal macrophages, even 30 weeks after tamoxifen treatment (Fig. 4a) . Histological examination confirmed the flow cytometry data and revealed a high percentage of Iba-1-labeled mMΦ, pvMΦ and cpMΦ that coexpressed YFP (Fig. 4b) . Quantitative examination on histological slices showed constant high expression of the reporter gene in mMΦ and pvMΦ, comparable to what we observed in microglia (Fig. 3d) . These data indicate that mMΦ and pvMΦ are stable populations that do not undergo substantial exchange with blood cells over 46 weeks. In contrast, YFP-labeling progressively dropped in Iba-1 + cpMΦ, suggesting a slow continuous exchange with blood cells. As a result of their transient nature Cx3cr1-targeted Ly6C lo monocytes in the blood lost their YFP reporter very rapidly and were quickly replaced by the non-targeted progeny 25, 26, 30 . Confocal analysis further confirmed the long-term persistence of pvMΦ in perivascular spaces of cerebral vessels (limited by laminin + basement membranes) at 8 weeks after tamoxifen treatment (Fig. 4c,d ). At this time point, microglia were still labeled, but blood monocytes were not (Fig. 4e) . Notably, we detected YFP-expressing mMΦ and cpMΦ by immunoelectron microscopy 30 weeks after recombination (Fig. 4f) . Labeled cpMΦ were found in close proximity to the microvilli of the choroid plexus epithelium, indicating that these cells represent Kolmer's epiplexus cells.
To further analyze whether the presence of these long-lived myeloid cells in distinct CNS microenvironments shapes their dynamic behavior, we imaged fluorescently labeled mMΦ, pvMΦ and microglia of living Cx3cr1 CreER Rosa26-Tomato mice at 8 weeks after tamoxifen treatment by confocal and in vivo two-photon (2p) microscopy. We found Tomato + cells in the subdural meninges, perivascular space and choroid plexus that expressed the markers F4/80 and CD206, indicating their macrophage nature ( Fig. 5a and Supplementary  Fig. 4b ). 2p time-lapse imaging revealed that mMΦ, pvMΦ and microglia, which are all embryo derived, can be differentiated in vivo not only on the basis of their anatomical location, but also of their characteristic morphology and distinct dynamic behavior (Fig. 5b-e and Supplementary Videos 1 and 2) . Consistent with previous 
Choroid plexus , one independent experiment with three mice (e,f), two independent experiments with n = 4 mice (mMΦ), n = 3 mice (cpMΦ) and n = 8 mice (microglia) (c) or n = 5 mice (mMΦ and pvMΦ), n = 4 mice cpMΦ) or n = 13 mice (microglia) (d) (mean ± s.e.m.), one independent experiment (g,h; Sfpi1) or three independent experiments (g,h; Irf8 and Myb). 31, 32 , microglial cells showed a ramified morphology with highly dynamic processes and a rather stationary cell body. In contrast, mMΦ often presented with a more ameboid morphology, and about a third of these cells (62 of 172 cells) moved over time (Fig. 5e,f) . These cell types could be further differentiated from pvMΦ, which followed the blood vessel outline and rarely displaced their cell body (5 of 44 cells), but constantly extended and retracted their protrusions along the blood vessel wall.
To evaluate a possible contribution of blood cells to the pool of macrophages at CNS boundaries under homeostatic conditions, we needed a method for tracking circulating cells without affecting the CNS environment or resident cells. Thus, we induced peripheral blood . Insets, high-resolution pictures of electron-dense precipitates associated with the cell bodies of mMΦ and cpMΦ. E, epithelium; P, parenchyma. Scale bars, 1 µm (left) and 2 µm (right). Data are from two independent experiments with five mice (a), two independent experiments with three mice (b), one independent experiment with three mice (c, left), two independent experiments (c, right; mean ± s.e.m. of n = 18 mice (microglia), n = 15 mice (pvMΦ), n = 13 mice (mMΦ) or n = 14 mice (cpMΦ)), three independent experiments with three mice (d), two independent experiments (e; n = 5 mice for microglia; n = 3 for Ly6C lo and Ly6C hi monocytes) or one independent experiment with two mice (f). 
A r t i c l e s chimerism by surgically joining two syngeneic mice, one of which ubiquitously expressed GFP (Acta1-GFP). These parabiotic mice established a rich anastomotic circulation, which quickly led to efficient blood chimerism in peripheral Ly6C hi and Ly6C lo monocytes (Fig. 6a) 33 . However, there was no detectable circulatory exchange of mMΦ and pvMΦ after 5 months of parabiosis, whereas donor-derived blood cells contributed to the cpMΦ population (Fig. 6a) . Furthermore, low gene recombination of mMΦ and pvMΦ in Flt3 Cre Rosa26-YFP animals suggested that their development occurred largely independently of Flt3 + multipotent hematopoietic precursors in the BM compared with the high percentage of YFP + myeloid cells in the circulation (Fig. 6b) . Again, only cpMΦ displayed a higher recombination of this gene, suggesting a role for hematopoietic stem cells in the development of cpMΦ. Furthermore, we found that neither Ly6C hi nor Ly6C lo monocytes were essential for mMΦ and pvMΦ development, as mice lacking Ccr2 or Nr4a1 presented normal proportions of these macrophages subsets (Fig. 6c) . Only cpMΦ were reduced in Ccr2-deficient mice, indicating that Ly6C hi monocytes contribute to their homeostasis. In sum, these data clearly indicate that non-parenchymal MΦ, such as mMΦ and pvMΦ, share their longevity with microglia without any input from blood monocytes (Supplementary Fig. 5 ). Only cpMΦ are exceptional, which, because of their dual origin, have a partial input from the circulation and a shorter turnover.
DISCUSSION
Our results describe the molecular signatures of tissue macrophages at CNS boundaries, their developmental pathways and the key mechanisms that ensure their homeostasis. By using large-scale single-cell RNA sequencing, we were able to dissect the individual transcriptional profiles of cortical pvMΦ and parenchymal myeloid cells (microglia) in the CNS and found a close relationship between these cells that was not shared by circulating monocytes or ptMΦ. Our unbiased 
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A r t i c l e s high-throughput methodology allowed us to define extensive functional specialization between cell classes 18 . In fact, we found that the marker Mrc1 was enriched in macrophages at CNS interfaces, whereas P2ry12 was expressed only by microglia, which confirms previous data that used expression profiling of several thousands of cells in the CNS 34, 35 . However, our finding that mMΦ, pvMΦ and cpMΦ have only limited relation to circulating myeloid cells represents a major conceptual change in the field. Since the 1980s, it has been assumed, A r t i c l e s based on BM chimera data using whole-body irradiation, that macrophages at CNS interfaces are blood derived 9 . The involvement of the CNS during the irradiation procedure clearly leads to substantial local priming with concomitant induction of myelo-attracting and myelopromoting factors and damage of the BBB 7,13-15 . Consequently, all previous studies on mMΦ, pvMΦ and cpMΦ using these techniques to establish BM chimeras have to be interpreted with caution. Tissue macrophages arise from two distinct embryonic developmental programs: early yolk sac-derived erythromyeloid progenitors (EMPs) that give rise to macrophages without monocyte intermediates and fetal monocytes that derive from MYB + EMPs generated in the yolk sac 7, 22, 36 . These pathways contribute differentially to macrophage development in several tissues, including the aorta, brain, skin, heart, liver and lung 7, 22, 24, [37] [38] [39] . Consistent with these findings, we found Cx3cr1-GFP + mMΦ, pvMΦ and cpMΦ during early embryogenesis, and fate-mapping approaches confirmed the persistence of embryo-derived CNS macrophages in embryonic, as well as in adult, mice. Development and homeostasis of CNS macrophages is not uniform. Similar to microglia, the maintenance of mMΦ and pvMΦ did not depend on circulating monocytes, and non-parenchymal CNS macrophages persisted over a very long period of time.
This is in contrast with cpMΦ, which show features of relative transience (compared with other CNS MΦ) and some replenishment by blood cells. A report conflicting with this interpretation suggests a different origin for all tissue macrophages, with the exception microglia, namely that they are derived from sources of definitive (fetal) hematopoiesis 40 . Using our Cx3cr1 CreER Rosa26-YFP fate-mapping system that tracks distinct yolk sac cells, we were able to clearly show that, in contrast with this earlier report 40 and in agreement with another study 22 , several other tissues such as the subdural meninges, the cerebral perivascular space and the choroid plexus contain MΦ that are derived from early embryonic precursors and remain there until adulthood.
Flt3 is expressed only by definitive hematopoietic progenitors in the embryo and during adulthood 41 . It can therefore be used to distinguish yolk sac-derived versus BM-derived macrophages 42 . This approach helped us to define cpMΦ as a distinct population of CNS macrophages that is different from mMΦ, pvMΦ and microglia that only have a negligible input from Flt3-dependent definitive hematopoiesis. CpMΦ development from circulating monocytes was confirmed by our results from the parabiosis experiments and in Ccr2-deficient mice. In contrast, genetic labeling using the tamoxifen-inducible Cx3cr1 CreER Rosa26-YFP system revealed that mMΦ and pvMΦ remained markedly stable when compared between embryonic and adult animals, arguing against a substantial contribution of BM-derived monocytes to these macrophages population, which is in contrast with other tissue macrophage populations such as in the liver and gut 22 . However, the small portion of Flt3-dependent YFP-labeled mMΦ and pvMΦ could also indicate another cellular origin of mMΦ and pvMΦ except from the yolk sac, namely from yolk sac-derived EMPs or monocytes that seed the fetal liver. Using our Cx3cr1 CreER Rosa26-YFP fate mapping system, we could not distinguish between these different embryonic sources.
Neurological diseases in which the choroid plexus is crucially involved as one of the interfaces between periphery and CNS are abundant 43 . Several lines of evidence suggest a fundamental involvement of the choroid plexus in the development and progression of multiple sclerosis (MS) and its animal model EAE. First, choroid plexus inflammation with immune cell activation and infiltration has been described preceding parenchymal inflammation and clinical disease onset in humans and mice 44 . Second, auto-aggressive sentinel T cells are thought to enter the cerebrospinal fluid through the choroid plexus during incipient stages of MS and EAE, and then travel to the subarachnoidal space, where they are reactivated by local antigen-presenting cells (APCs) presenting cognate antigen 45 . These findings all argue for the dual role of the choroid plexus as an immune cell-modulatory site, as well as an entry gate for peripheral immune cells to the CNS during neuroinflammation.
Strategically positioned at the CNS barriers, mMΦ, pvMΦ and cpMΦ might modulate immune cell entry and phenotype. The myeloid cells in the CNS-adjoining tissues have been implicated in various immunopathological processes, including antigen presentation to circulating lymphocytes [46] [47] [48] . As presumed guardians of tissue homeostasis, the CNS-surrounding myeloid cell network appears to be crucially involved in the development, progression and resolution of neuroinflammatory, neurodegenerative and neurooncological diseases. Our results will help to unravel mMΦ, pvMΦ and cpMΦ function in vivo in more detail and to identify new means to manipulate these cells for the treatment of neural diseases.
METHODS
Methods and any associated references are available in the online version of the paper. 
